Home > Qtrly Results > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
Audited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Revenues ₹73 Cr ₹77 Cr ₹66 Cr ₹60 Cr ₹61 Cr ₹55 Cr ₹66 Cr ₹81 Cr
Expenses ₹69 Cr ₹67 Cr ₹56 Cr ₹46 Cr ₹47 Cr ₹44 Cr ₹57 Cr ₹68 Cr
Operating Income ₹4 Cr ₹11 Cr ₹10 Cr ₹13 Cr ₹14 Cr ₹11 Cr ₹9 Cr ₹13 Cr
Other Income ₹4 Cr ₹-4 Cr ₹-2 Cr ₹-2 Cr ₹0 Cr ₹0 Cr ₹-1 Cr ₹0 Cr
Interest ₹1 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹1 Cr
Profit Before Tax ₹6 Cr ₹6 Cr ₹7 Cr ₹11 Cr ₹14 Cr ₹16 Cr ₹-39 Cr ₹11 Cr
Profit After Tax ₹5 Cr ₹5 Cr ₹6 Cr ₹11 Cr ₹14 Cr ₹14 Cr ₹-41 Cr ₹8 Cr
EPS ₹0.97 ₹0.83 ₹1.17 ₹2.01 ₹13.29 ₹2.82 ₹-8.08 ₹1.59
Industry Peers & Returns1W1M1Y
BALAXI PHARMACEUTICALS -1.8% 25% -34.6%
ADANI ENTERPRISES 0.7% 10.7% -25.6%
REDINGTON -5.9% -8.5% 18.5%
MMTC 0.6% 6.1% -21.5%
HONASA CONSUMER -1.4% 4.7% -41.4%
LLOYDS ENTERPRISES 9.8% 1.7% 57.9%
ENTERO HEALTHCARE SOLUTIONS 2.2% -7.8% 13.7%
OPTIEMUS INFRACOM 0.4% -5.5% 65.9%
POLO QUEEN INDUSTRIAL & FINTECH -14.3% -49.8% 36.1%

BALAXI PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-5.29 %

Y-o-Y

20.57 %

Quarters Revenues % Change
Dec2024 ₹73 Cr
-5.29
Sep2024 ₹77 Cr
17.92
Jun2024 ₹66 Cr
9.68
Mar2024 ₹60 Cr
-1.57
Dec2023 ₹61 Cr
11.08
Sep2023 ₹55 Cr
-17.03
Jun2023 ₹66 Cr
-18.25
Mar2023 ₹81 Cr -

BALAXI PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-62.34 %

Y-o-Y

-70.81 %

Quarters Operating Profit % Change
Dec2024 ₹4 Cr
-62.34
Sep2024 ₹11 Cr
4.97
Jun2024 ₹10 Cr
-25.11
Mar2024 ₹13 Cr
-1.41
Dec2023 ₹14 Cr
26.90
Sep2023 ₹11 Cr
21.76
Jun2023 ₹9 Cr
-30.63
Mar2023 ₹13 Cr -
Operating Margins
Q-o-Q

-60.23 %

Y-o-Y

-75.79 %

Quarters Operating Margin% % Change
Dec2024 5.44%
-60.23
Sep2024 13.68%
-11.00
Jun2024 15.37%
-31.72
Mar2024 22.51%
0.18
Dec2023 22.47%
14.23
Sep2023 19.67%
46.79
Jun2023 13.4%
-15.19
Mar2023 15.8% -

BALAXI PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

16.87 %

Y-o-Y

-60.56 %

Quarters Profit After Tax % Change
Dec2024 ₹5 Cr
16.87
Sep2024 ₹5 Cr
-29.20
Jun2024 ₹6 Cr
-40.74
Mar2024 ₹11 Cr
-19.57
Dec2023 ₹14 Cr
-5.78
Sep2023 ₹14 Cr
Positive
Jun2023 ₹-41 Cr
Negative
Mar2023 ₹8 Cr -
PAT Margins
Q-o-Q

23.44 %

Y-o-Y

-67.26 %

Quarters PAT Margin(%) % Change
Dec2024 7.32 %
23.44
Sep2024 5.93 %
-39.92
Jun2024 9.87 %
-45.98
Mar2024 18.27 %
-18.29
Dec2023 22.36 %
-15.21
Sep2023 26.37 %
Positive
Jun2023 -62.68 %
Negative
Mar2023 10.04 % -

BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

16.87 %

Y-o-Y

-92.70 %

Quarters EPS % Change
Dec2024 ₹0.97
16.87
Sep2024 ₹0.83
-29.06
Jun2024 ₹1.17
-41.79
Mar2024 ₹2.01
-84.88
Dec2023 ₹13.29
371.28
Sep2023 ₹2.82
Positive
Jun2023 ₹-8.08
Negative
Mar2023 ₹1.59 -

You may also like the below Video Courses